AKT1 and neoplasm: When the content of ROS is insufficient to break the balance between oxidative and antioxidant systems in the tumor growth environment, it can participate in the regulation of epithelial-mesenchymal transition (EMT), tumor angiogenesis, and other processes by activating PI3K/Akt and NF-κB signaling pathways [12–14].